Compass Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-372,621
| Closed | -$25.2M | – | 44 |
|
|
2018
Q2 | $25.2M | Buy |
372,621
+32,318
| +9% | +$2.19M | 3.67% | 21 |
|
|
2018
Q1 | $24.7M | Buy |
340,303
+12,680
| +4% | +$919K | 3.69% | 19 |
|
|
2017
Q4 | $24.6M | Buy |
327,623
+10,860
| +3% | +$817K | 3.73% | 20 |
|
|
2017
Q3 | $24.4M | Buy |
316,763
+1,460
| +0.5% | +$112K | 3.87% | 14 |
|
|
2017
Q2 | $23.6M | Buy |
315,303
+3,358
| +1% | +$251K | 3.84% | 18 |
|
|
2017
Q1 | $20.8M | Buy |
311,945
+8,911
| +3% | +$593K | 3.57% | 23 |
|
|
2016
Q4 | $19.8M | Buy |
303,034
+23,236
| +8% | +$1.52M | 3.69% | 21 |
|
|
2016
Q3 | $19.8M | Buy |
279,798
+3,926
| +1% | +$278K | 3.72% | 19 |
|
|
2016
Q2 | $20.4M | Buy |
275,872
+36,655
| +15% | +$2.71M | 3.9% | 12 |
|
|
2016
Q1 | $15.5M | Buy |
239,217
+17,043
| +8% | +$1.11M | 3.09% | 25 |
|
|
2015
Q4 | $17.1M | Buy |
222,174
+10,696
| +5% | +$825K | 3.63% | 20 |
|
|
2015
Q3 | $17.4M | Buy |
211,478
+1,217
| +0.6% | +$100K | 3.91% | 13 |
|
|
2015
Q2 | $18.5M | Sell |
210,261
-2,095
| -1% | -$185K | 3.91% | 14 |
|
|
2015
Q1 | $18.8M | Buy |
212,356
+2,769
| +1% | +$245K | 3.91% | 11 |
|
|
2014
Q4 | $17.4M | Sell |
209,587
-972
| -0.5% | -$80.7K | 3.72% | 16 |
|
|
2014
Q3 | $17.8M | Sell |
210,559
-744
| -0.4% | -$62.8K | 3.42% | 7 |
|
|
2014
Q2 | $17.1M | Sell |
211,303
-4,217
| -2% | -$342K | 3.32% | 9 |
|
|
2014
Q1 | $16.4M | Buy |
215,520
+2,093
| +1% | +$159K | 3.28% | 12 |
|
|
2013
Q4 | $15.4M | Buy |
213,427
+3,399
| +2% | +$245K | 3.1% | 18 |
|
|
2013
Q3 | $14.4M | Buy |
210,028
+4,527
| +2% | +$311K | 3.25% | 11 |
|
|
2013
Q2 | $13M | Buy |
+205,501
| New | +$13M | 3.17% | 14 |
|